Type 2 familial partial lipodystrophy (FPLD2; MIM: #151660) or Dunnigan disease results from heterozygous or compound heterozygous variants affecting mainly exons 8 and 11 of LMNA gene (1q21–22, NC_000001.11), although variants in other exons have been reported [17,18]. Here, LMNA is linked to familial partial lipodystrophy, Dunnigan type.